HIPEC combined with camrelizumab, paclitaxel and S-1 for conversion therapy in patients with advanced gastric cancer with peritoneal metastasis: A prospective phase II clinical study.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.e16017
Abstract: e16017 Background: This phase II study aimed to evaluate the efficacy and safety of systemic chemoimmunotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) combined with cytoreductive surgery (CRS) for the treatment of gastric cancer (GC) patients with… read more here.
Keywords: hipec combined; conversion; group; conversion therapy ... See more keywords